Phase III trial of anti-tau drug generates mixed messages
Crossref DOI link: https://doi.org/10.1038/nrneurol.2016.120
Published Online: 2016-08-12
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wood, Heather
Text and Data Mining valid from 2016-08-12
Article History
First Online: 12 August 2016